RE: RE: RE: RE: RE: RE: RE: GeezuzTN-I didn't say 'worthless', but o.k., I'll say 'marginal', lol.
Look at it this way. According to Stockhouse, rpm.v has a market cap of $47.5 million. Stockhouse is often low on market cap, but let's go with what they currently have up there. This is not opinion. This is a fact. Based on known information, this is what investors are paying for the company.
So let's apportion that $47.5 million among the 5 properties according to our own best judgement. Or as richie rich says, let's all do our dd, and post what our dd tells us. I know, I know, some will say that rpm.v is undervalued. Every stock in the whole wide world is undervalued, in the eyes of the longs that have purchased the stock, lol.
So here goes. My dd tells me that Lincoln, based on information available to the general public, is worth at least half of the market cap. Let's say $24 million. In other words, if they split the company into two pieces, Lincoln in one stock and everything else in another, I'm guessing that half the value would go to Lincoln, and all the other stuff would get the remainder.
So if Lincoln is worth $24 million to today's investors, then Wilco, GoldRidge, Jessup, and GGP COMBINED are also worth about $24 million.
Of course the stock price might go up. I hope it goes up. But they have released many Wilco assays this year and they didn't budge the stock price. And I think the stock tanked the last time they released Jessup results, remember that disaster?
And now they are dragging their feet in terms of releasing Lincoln results, which can't be good, for the core program. But maybe they will soon get some RC assays that are decent and the stock price will rise following their release. But there again, that will be a function of the investing public admiring Lincoln, not Wilco. IMHO, do your own dd, lol